IRCT20200105046010N71招募中未知
In- Vivo Bioequivalence study of Esmoprazole 10 mg Sachet. Teb Mofid Nikan Co.(Pylorinex) with brand drugs (Nexium ® 10 mg Sachet, AstraZeneca, UK) in Iranian healthyvolunteers.
Teb Mofid Nikan Pharmaceutical Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index between18-28
- •Informed consent
- •Being at the age of 18-55 years old
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
尚未招募
不适用
Bioequivalence study of manufactured by Esmoprazole 40mg Cap. Kooshan Pharmed. Co. (Eosoflux) in Iranian healthy volunteersIRCT20200105046010N7Tabriz University of Medical Sciences24
尚未招募
4 期
Bioequivalence study of esomeprazole 20 mg (Capsule vs Tablet) in healthy Thai volunteers under fasting and fed conditionsHealthy volunteersTCTR20201125002Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University89
招募中
Unknown
Investigating bioequivalence of Omeprazole capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N16Tabriz University of Medical Sciences24
招募中
Unknown
Bioequivalence study of tablets of Esomeprazole 40 mgIRCT20230222057495N17Koushan Pharmed Pharmaceutical Company24
招募中
不适用
Study of absorption and elimination rate of omeprazole 20 mg capsule in comparison with omeprazole brand capsules (Prilosec®).bioequivalence study.IRCT20200407046981N19Yas Kavir Meybod Pharmaceutical Company24